|HomeAbout UsPatient CareEducationResearchLinks|
The Uro-oncology Fellowship Program
The Urologic Oncology Fellowship Program at Indiana University began in the 1980ís under the direction of Dr. John Donohue, and later accredited by the Society of Urologic Oncology (SUO) in 2001. Our fellowship is a two-year program comprised of one research year followed by one year of clinical fellowship. Consistent with the mission of the SUO, our goal is to provide a comprehensive training program in clinical genitourinary oncology through advanced surgical training, multidisciplinary didactics, and clinical/translational research endeavors.
During the first year of fellowship, opportunities to participate in clinical, translational and basic science research are available. Areas include protocol development and clinical trial design, collaboration and coordination of translational projects with researchers at Indiana University and Purdue University, and health services and outcomes based study. Basic science research is focused on genetic and translational approaches to the treatment and management of urologic malignancies. Participation in abstract presentation at regional and national meetings and authorship in peer-reviewed publications will be encouraged. The fellow will be responsible for leading a weekly multidisciplinary cancer conference. Opportunities to rotate with our medical oncology and radiation oncology colleagues will be coordinated during this year. Additionally, the fellow will serve as a clinical staff at our county hospital, participating in autonomous resident supervision and teaching. Overall, clinical responsibilities during the first year comprises <10% of the fellows time, with the remaining time protected for research and academic endeavors.
The second year of fellowship is dedicated to clinical time in the operating room. Fellows will participate in a wide array of open and minimally invasive procedures performed under the supervision of our urologic oncology staff. Our clinical experience in complex oncologic and reconstructive surgery is unparalleled, boasting one of the largest surgical experiences in testicular and advanced bladder cancer in the world.
The Urologic Oncology Faculty
Urologic Oncology Fellowship Alumni
The urology oncology fellowship program at the Indiana University School of Medicine has been in existence since the 1980ís and later accredited by the Society of Urologic Oncology (SUO) in 2001.
The fellowship program is two years long. It is divided into one year of clinical urologic oncology training and one year of urologic oncology research. Residents completing an ACGME accredited urology residency program or a similarly accredited international residency program in urology are eligible for application.
The clinical training year provides a broad exposure to routine and complex urologic oncology conditions. The fellowship includes education in the multidisciplinary approach to urologic cancer care, including exposure to radiation oncology, medical oncology, urologic cancer pathology and supportive care.
Surgical training during the clinical year includes adequate exposure to both minimally invasive and open surgical procedures. Although the ratio of minimally invasive and open surgical experience during this training will vary, fellows will be provided with a volume of surgical training in both that will allow the graduating fellow to perform both open and minimally invasive surgery with competence. Adequate exposure to complex open surgical procedures is an important part of this training. Although typical case volumes for our graduating fellows are significantly larger than the minimum requirements, the requirement for each index case involves a minimum of 30 prostatectomy, 25 nephrectomy, 15 cystectomy, and 5 retroperitoneal node dissection cases. The average graduating fellow performs 2-3 times the minimum number of cystectomies required and 10-15 times the minimum number of required retroperitoneal lymph node dissection cases. (see case logs listed in chart below)
Case log numbers from the 8 most recent fellows (Not in any particular order)
The research training year consists of a health services track or laboratory research, or may include a combination of both. The research year includes at least 80% protected time for conducting research without clinical responsibilities. The department has robust research databases in the major urologic cancers and can also provide experience working with larger population-based datasets as well. The research training provides the fellow with a valuable educational experience that will result in peer-reviewed publications in urologic cancer journals. Research training also includes instruction in evidence-based medicine, clinical trial design, biostatistics, and grant writing. Fellows also receive education in the basic science and molecular aspects of urologic cancer. Research opportunities may be EITHER in health services research or basic science research although SUO accredited institutions are encouraged to offer both options.
More details of the requirements governed by the SUO are available on the website at http://suonet.org.
Should you have any further questions or require any additional information, please donít hesitate to contact me.
Looking forward to meeting you soon!
Timothy Masterson, MD
Alternate Program Contact: